Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress.
The healthy volunteer trial, conducted by the collaborative nanomedicine research programme led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, and in collaboration with the St Stephen’s AIDS Trust at the Chelsea & Westminster Hospital in London, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. The results were from two trials which are the first to use orally dosed nanomedicine to enable HIV therapy optimisation.
Manipulation of matter
Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the prevention and treatment of disease in the human body. By developing smaller pills that are better for patients and less expensive to manufacture, this evolving discipline has the potential to dramatically change medical science and is already having an impact in a number of clinically used therapies and diagnostics worldwide.
Currently, the treatment of HIV requires daily oral dosing of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.
Developing new therapies
Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.
The trial results confirmed the potential for a 50 percent dose reduction while maintaining therapeutic exposure, using a novel approach to formulation of two drugs: efavirenz (EFV) and, lopinavir (LPV). EFV is the current WHO-recommended preferred regimen, with 70% of adult patients on first-line taking an EFV-based HIV treatment regimen in low- and middle-income countries.
The trial is connected to the University’s ongoing work as part of the multinational consortium OPTIMIZE, a global partnership working to accelerate access to simpler, safer and more affordable HIV treatment. Funded by the U.S. Agency for International Development, OPTIMIZE is led by the Wits Reproductive Health & HIV Institute in Johannesburg, South Africa, and includes the interdisciplinary Liverpool team, Columbia University, Mylan Laboratories and the Medicines Patent Pool (MPP). OPTIMIZE is supported by key partners including UNITAID and the South African Medical Research Council (SAMRC).
Benny Kottiri, USAID’s Office of HIV/AIDS Research Division Chief, said: “The potential applications for HIV treatment are incredibly promising. By aligning efforts, these integrated investments offer the potential to reduce the doses required to control the HIV virus even further, resulting in real benefits globally. This would enable the costs of therapy to be reduced which is particularly beneficial for resource-limited countries where the burden of disease is highest.”
To watch the presentation please click here.
Receive an email update when we add a new HIV article.
The Latest on: HIV
via Google News
The Latest on: HIV
- US charges man accused of Singapore HIV data leak on February 23, 2019 at 5:00 am
An American man accused of leaking data of thousands of HIV-positive people in Singapore has been charged in the United States with possession and unlawful transfer of stolen documents, authorities sa... […]
- United States charges man accused in leak of Singapore HIV data on February 22, 2019 at 10:49 pm
SINGAPORE (Reuters) - Authorities in the United States have charged a man accused of leaking information on thousands of HIV victims in Singapore with possession and unlawful transfer of stolen docume... […]
- Florida cannot afford empty promises to end HIV | Opinion on February 22, 2019 at 2:20 pm
During his recent State of the Union address, President Trump committed to ending new HIV transmissions by 2030. His pledge comes at a time when Florida leads the nation in AIDS diagnoses, and South F... […]
- Report: HIV risk could be cut by 67 percent by 2030 on February 22, 2019 at 11:55 am
Feb. 22 (UPI) --President Donald Trump Trump announced a goal of reducing new HIV infections by 90 percent, but a new study says that may not be possible. New research predicts that HIV infections are ... […]
- Study: HIV infections in US could be reduced by up to 67 percent by 2030 on February 22, 2019 at 9:11 am
New HIV infections in the United States could be substantially reduced by up to 67 percent by 2030 if ambitious goals for HIV care and treatment are met and targeted prevention interventions for ... […]
- What Parents and Providers Need to Know About HIV Risk and Teens on February 22, 2019 at 8:00 am
The average teenager feels as if she or he could not possibly get HIV. Most believe that HIV only happens to other people. However, teens represent a growing share of people getting and living with HI... […]
- HIV infections in US could be reduced by up to 67 percent by 2030, study finds on February 22, 2019 at 7:58 am
ATLANTA--New HIV infections in the United States could be substantially reduced by up to 67 percent by 2030 if ambitious goals for HIV care and treatment are met and targeted prevention interventions ... […]
- African-American women with HIV often overlooked, under-supported on February 22, 2019 at 4:07 am
The face of HIV in the United States has long been white gay men, even though the epidemic has had a devastating and disproportionate impact on African-American communities. This is especially true am... […]
- An HIV data leak has left a community in fear on February 21, 2019 at 4:36 pm
Just a few weeks ago, "Joyce" received a phone call that threw her life in the air. Joyce is HIV positive, and was told in the call that this information - along with details of more than 14,000 other ... […]
via Bing News